Backs FY25 revenue view up 5%-8%. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks on TipRanks >> Read More on HAE: Haemonetics reports Q2 adjusted EPS $1.12, consensus $1.07 HAE Earnings Report this Week: Is It a Buy, Ahead of Earnings? Moderna, Halliburton downgraded: Wall Street’s top analyst calls Haemonetics initiated with a Buy at CL King Haemonetics management to meet with Barrington Disclaimer & DisclosureReport an Issue
